211 related articles for article (PubMed ID: 34890078)
21. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
[TBL] [Abstract][Full Text] [Related]
22. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
23. Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift of focus from target range to proportion in range.
Sivasubramaniyam S; Amiel SA; Choudhary P
Diabet Med; 2017 Oct; 34(10):1456-1460. PubMed ID: 28763121
[TBL] [Abstract][Full Text] [Related]
24. Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study.
Wang X; Wu G; Shen D; Zhang X; Yang W
Adv Ther; 2022 Jun; 39(6):2820-2830. PubMed ID: 35430674
[TBL] [Abstract][Full Text] [Related]
25. Intensified follow-up of patients with type 1 diabetes and poor glycaemic control: a multicentre quality improvement collaborative based on data from the Norwegian Diabetes Register for Adults.
Vonheim Madsen T; Cooper JG; Carlsen S; Loevaas K; Rekdal M; Igland J; Sandberg S; Ueland GÅ; Iversen MM; Sølvik U
BMJ Open Qual; 2023 Jun; 12(2):. PubMed ID: 37308253
[TBL] [Abstract][Full Text] [Related]
26. Inequalities in glycemic control in childhood onset type 2 diabetes in England and Wales-A national population-based longitudinal study.
Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Stephenson T
Pediatr Diabetes; 2019 Nov; 20(7):821-831. PubMed ID: 31329349
[TBL] [Abstract][Full Text] [Related]
27. Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.
Whyte MB; Joy M; Hinton W; McGovern A; Hoang U; van Vlymen J; Ferreira F; Mount J; Munro N; de Lusignan S
Diabetes Obes Metab; 2022 Jul; 24(7):1310-1318. PubMed ID: 35373891
[TBL] [Abstract][Full Text] [Related]
28. Flash monitor initiation is associated with improvements in HbA
Jeyam A; Gibb FW; McKnight JA; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; Kennon B; McCrimmon RJ; Leese G; Philip S; Sattar N; McKeigue PM; Colhoun HM;
Diabetologia; 2022 Jan; 65(1):159-172. PubMed ID: 34618177
[TBL] [Abstract][Full Text] [Related]
29. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes - a nationwide cross-sectional study.
Svedbo Engström M; Leksell J; Johansson UB; Borg S; Palaszewski B; Franzén S; Gudbjörnsdottir S; Eeg-Olofsson K
Health Qual Life Outcomes; 2019 Aug; 17(1):141. PubMed ID: 31412881
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial.
Davies MJ; Rosenstock J; Ali A; Russell-Jones D; Souhami E; Palmer K; Ji C; Niemoeller E; Skolnik N
Diabetes Obes Metab; 2022 Jan; 24(1):34-41. PubMed ID: 34617398
[TBL] [Abstract][Full Text] [Related]
32. Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs.
Mata-Cases M; Mahon J; Mauricio D; Franch-Nadal J; Real J; Hex N
BMC Health Serv Res; 2020 Aug; 20(1):803. PubMed ID: 32847581
[TBL] [Abstract][Full Text] [Related]
33. Paediatric estimated average glucose in children with Type 1 diabetes.
O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
[TBL] [Abstract][Full Text] [Related]
34. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
[TBL] [Abstract][Full Text] [Related]
35. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela.
G Duarte F; da Silva Moreira S; Almeida MDCC; de Souza Teles CA; Andrade CS; Reingold AL; Moreira ED
BMJ Open; 2019 Mar; 9(3):e023401. PubMed ID: 30842107
[TBL] [Abstract][Full Text] [Related]
36. A carbohydrate-reduced high-protein diet improves HbA
Skytte MJ; Samkani A; Petersen AD; Thomsen MN; Astrup A; Chabanova E; Frystyk J; Holst JJ; Thomsen HS; Madsbad S; Larsen TM; Haugaard SB; Krarup T
Diabetologia; 2019 Nov; 62(11):2066-2078. PubMed ID: 31338545
[TBL] [Abstract][Full Text] [Related]
37. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.
Lind M; Pivodic A; Cea-Soriano L; Nerman O; Pehrsson NG; Garcia-Rodriguez LA
Diabetologia; 2014 Aug; 57(8):1586-94. PubMed ID: 24811709
[TBL] [Abstract][Full Text] [Related]
38. Glycemic outcomes among rural patients in the type 1 diabetes T1D Exchange registry, January 2016-March 2018: a cross-sectional cohort study.
Gill A; Gothard MD; Briggs Early K
BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35042753
[TBL] [Abstract][Full Text] [Related]
39. Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model.
Oke JL; Stevens RJ; Gaitskell K; Farmer AJ
Diabet Med; 2012 Feb; 29(2):266-71. PubMed ID: 21838767
[TBL] [Abstract][Full Text] [Related]
40. Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
Jensen MH; Cichosz SL; Gustenhoff P; Nikontovic A; Hejlesen O; Vestergaard P
PLoS One; 2022; 17(10):e0274626. PubMed ID: 36240184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
